Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing more than 2 million treatments worldwide with DUROLANE, its single-injection, hyaluronic acid (HA) product used in the treatment of pain associated with osteoarthritis (OA). DUROLANE is the original single injection hyaluronic acid therapy, has helped patients in nearly 30 countries and is a trusted therapy for clinicians in the management of OA.
Proven safe and effective, DUROLANE has more clinical studies than any other US single-injection HA, and has also been proven to provide greater reduction in OA knee pain versus Synvisc-One®.1,2 It has longer lasting pain relief versus a steroid injection, is safe and repeated use of DUROLANE does not increase the incidence of adverse events.3,4
DUROLANE is available in its original 3ml syringe for treatment of large joints and in a 1ml syringe, known as DUROLANE SJ, to enable treatment of small joints.* Both are produced using a natural, safe and proven technology called NASHA ® . This process yields a high molecular weight stabilized HA, which is a naturally occurring molecule that provides lubrication and cushioning in a normal joint.
“The US launch of DUROLANE in 2018 boosted our growth to more than 2 million treatments and we are very proud of this milestone. Still, there are many more patients to reach,” said John Nosenzo, Chief Commercial Officer, Bioventus. “In the US, more than 14 million people are afflicted with knee OA and osteoarthritis overall affects more than 240 million globally.5,6 Returning people to active lifestyles is our commitment to the market and we are pleased that DUROLANE is serving the needs of clinicians and the OA patients they treat.”
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the company on LinkedIn and Twitter.
Bioventus, the Bioventus logo, and DUROLANE are registered trademarks of Bioventus LLC. NASHA is a registered trademark. Synvisc-One and Synvisc are registered trademarks of Genzyme Corporation.
*DUROLANE SJ is not available in the US.
Summary of Indication for Use: DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen. Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Full prescribing information can be found in product labeling, at www.DUROLANE.com , or by contacting Bioventus Customer Service at 1-800-836-4080.
NOTE: The above indications presented are for the US market; indications may vary by country. Contact your local Bioventus representative or visit www.durolane.com/uk/selection for prescribing information specific to your market.
1. McGrath AF, McGrath AM, Jessop ZM, et al. A comparison of intra-articular hyaluronic acid competitors in the treatment of mild to moderate knee osteoarthritis. J Arthritis. 2013; 2(1):108. doi:10.4172/2167-7921.1000108. 2. DOF RPT-001111 3. Leighton R, Åkermark C, Therrien R, et. al. NASHA hyaluronic acid vs methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage. 2014; 22(1):17-25. 4. DUROLANE [package insert]. Durham, NC: Bioventus LLC; 2017. 5. Arthritis Foundation. What is osteoarthritis? Accessed February 9, 2019. www.arthritis.org/about-arthritis/types/osteoarthritis/what-is-osteoarthritis.php 6. Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37 Suppl 120(5):3-6.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200922005067/en/
Contact information
Thomas Hill
919-474-6715
thomas.hill@bioventusglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aqara Showcases Latest Innovations in Spatial Intelligence at CES 20266.1.2026 17:12:00 EET | Press release
Aqara, a global leader and pioneer in IoT, today unveiled its cutting-edge innovations in intelligent space technology at CES 2026 (Booth #51229, Halls A-D, Venetian Expo). Aqara’s demonstration offers a glimpse into a smarter system that reshapes how spaces perceive and respond to human activity—delivering security, comfort, and convenience like never before. Key highlights include the new Thermostat Hub W200 with Adaptive Temperature and Clean Energy Guidance from Apple and Aqara’s first Matter-enabled Camera Hub G350, both of which act as centers for spatial intelligence, analyzing environmental data to manage devices and automation; the Spatial Multi-Sensor FP400 and Multi-State Sensor P100, which detect human presence, behavior, and environmental conditions; and the Smart Lock U400 that provides hands-free unlock with home key on iPhone or Apple Watch. Together, these devices enable a seamless, intuitive experience, transforming modern spaces—whether in residential, commercial, or
Andersen Global Broadens Tax Capabilities in Africa with Addition of Luca Pacioli6.1.2026 16:30:00 EET | Press release
Andersen Global enhances its footprint in North Africa through a Collaboration Agreement with Luca Pacioli, a tax, accounting, and corporate services firm headquartered in Tunisia with offices in Tunis and Sfax. Founded in 1986 by Mongi Ben Mahmoud and now led by Managing Partner Arcelin Ben Mahmoud, Luca Pacioli is registered with the Order of Chartered Accountants of Tunisia (OECT) and provides integrated tax, accounting, and corporate advisory services grounded in deep technical expertise and regulatory insight. The firm offers end-to-end support across tax advisory and planning, international taxation, and IBFD-certified transfer pricing, as well as tax disputes and litigation, compliance and HR services, financial reporting, and M&A advisory. Its comprehensive capabilities also extend to company formation and administration, corporate restructuring, and legal secretarial services, enabling local and international clients across sectors including financial services, manufacturing,
Amazfit Introduces the Future of Sports Technology at CES 20266.1.2026 16:00:00 EET | Press release
Amazfit, a leading global smart wearable brand by Zepp Health (NYSE: ZEPP), returns to CES 2026 with a bold vision for the future of sports technology. Long known for accessible, performance-driven wearables, the brand is entering a new era defined by thoughtful design, innovation, and an unmistakable athletic spirit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106362840/en/ At CES 2026, Amazfit will spotlight how its connected ecosystem supports the full spectrum of an active lifestyle powered by real-world use cases and trusted by elite athletes, including Derrick Henry, Gabby Thomas, Hunter McIntyre, and Grant Fisher. At CES 2026, Amazfit will spotlight how its connected ecosystem supports the full spectrum of an active lifestyle powered by real-world use cases and trusted by elite athletes, including Derrick Henry, Gabby Thomas, Hunter McIntyre, and Grant Fisher. Amazfit’s philosophy reflects a commitment to techno
SonicEdge Announces Semiconductor Integration Partnership at CES 2026 as Modulated Ultrasound Technology Gains Industry Adoption6.1.2026 16:00:00 EET | Press release
SonicEdge, a pioneer in micro-acoustic innovation, announced today at CES 2026 a new strategic partnership with a leading global semiconductor manufacturer to integrate its modulated ultrasound IP directly into next-generation audio chipsets. The audio chipset will natively drive SonicEdge’s modulated ultrasound speakers. Additional major chip companies are expected to follow as the industry recognizes modulated ultrasound as the enabling technology for AI-powered hearables and wearables. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106681554/en/ SonicEdge showcases latest technology advances to customers and partners at CES 2026 Semiconductor-Level Integration Accelerates Market Adoption This new strategic partnership with a leading global semiconductor manufacturer represents a significant milestone in modulated ultrasound technology adoption. By embedding SonicEdge IP at the silicon level, chip manufacturers can deli
Charted Launches UK Presence to Deliver ERP-Native AP Automation Across EMEA6.1.2026 16:00:00 EET | Press release
Charted, a leading accounts payable automation software and ERP services provider, today announced the official launch of its UK office, to support users in the UK and EMEA. This follows the launch of International Payments and an official rebrand in 2025, continuing the forward path of growth and expansion to assist accounts payable (AP) teams in streamlining their processes with advanced automation and deep AI capabilities. Charted began a decade ago as a consulting firm implementing ERPs for some of the world’s most complex organizations. After years of solving recurring accounts payable challenges for customers, Charted evolved that expertise into an ERP-native SaaS platform that streamlines end-to-end AP processes for multi-entity, multi-currency businesses. “Even with modern ERP systems in place, accounts payable remains one of the most manual and fragmented areas of finance, especially for organizations operating across regions, entities and currencies,” said Bernardo Enciso, CE
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom